Journal
NEUROSCIENCE LETTERS
Volume 491, Issue 3, Pages 181-186Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2011.01.032
Keywords
SUMO; SUMOylation; mGluR7; Ubc9; Ubiquitin; Post-translational modification; GPCR; mGluR7; Metabotropic glutamate receptor
Categories
Funding
- MRC
- Wellcome Trust
- European Research Council
- Medical Research Council [G0601810] Funding Source: researchfish
- MRC [G0601810] Funding Source: UKRI
Ask authors/readers for more resources
Group III metabotropic glutamate receptors (mGluRs) undergo post-translational modification by SUMO in in vitro assays but the SUMOylation of full-length mGluRs in mammalian cells has not been reported. Here we investigated SUMOylation of mGluR7 in HEK293 cells and primary cortical neurons in an attempt to confirm SUMOylation and define physiological effects on mGluR7 function. Using a recombinant bacterial expression assay we validated in vitro SUMOylation of the C-terminal domain of mGluR7 by both SUMO-1 and SUMO-2 and show that a single lysine residue (K889) in mGluR7 is required for SUMOylation. However, using a range of approaches, we were unable to detect SUMOylation of full-length mGluR7 in either heterologous cells or neurons. Further, we observed no differences in receptor stability or surface expression between wild-type and a non-SUMOylatable point mutant mGluR7. Thus, our results question whether mGluR7, and by implication other group III mGluRs, are physiologically relevant neuronal SUMO substrates. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available